Industry Trends

Physicians are in high demand — here’s how to find your new role

AANP offers five critical health care trends for next year.

Zocdoc’s 2024 “What Patients Want” report highlights year-over-year trends in patient preferences, behaviors and sentiments.

As health care sector readies for change in the White House, Big Cities Health Coalition outlines policy priorities for next year.

McKinsey & Company analyzed recent trends to explain how the health care industry can weather ongoing challenges, and capitalize on emerging opportunities, in a new report.

A new Medscape and HIMSS report found that AI in health care settings is primarily used for administrative tasks, with clinical applications still in the early stages of adoption.

As a result of shifts in the primary care landscape, Bain & Company has made important adjustments to their 2030 market share forecast from two years ago.

The regulatory battle over compounded semaglutide and health effects on the heart are among latest developments involving GLP-1 RA drugs.

Robert Kushner, MD, an expert in overweight, obesity, nutrition, diet and exercise, discusses the effects of the new antiobesity medications.

Independent oncologists are important for patient health and cost-effective care

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Pradeep Kumar Jain, senior director of health care at Tredence, outlined five significant predictions for 2025.

Employers face tough decisions on health care coverage as costs continue to rise.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Mental health treatment access is low while cost is high. Here’s what to know about digital solutions.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

O’Neill tapped to serve as deputy secretary, Bhattacharya to lead National Institutes of Health.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

On behalf of Patients for Safer Nuclear Medicine, we object to the content of Cathy Sue Cutler’s column dismissing efforts to improve nuclear medicine safety and transparency.

A physician researcher and author discusses the latest information on GLP-1 RA antiobesity medications.

Nearly 500,000 uninsured signed up for coverage in 2025

Researchers issue a call for action on health disparities among ethnic groups

Key objectives for the improvement of primary care at the state level were discussed in an expert-led AHCJ webinar, titled "No one can see you now."

Rising utilization and pharmacy costs, along with new technologies, blamed for the rise